Wird geladen...
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy
Hemophilia A (HA) and hemophilia B (HB) are X-linked bleeding disorders due to inheritable deficiencies in either coagulation factor VIII (FVIII) or factor IX (FIX), respectively. Recently, gene therapy clinical trials with adeno-associated virus (AAV) vectors and protein-engineered transgenes, B-do...
Gespeichert in:
| Veröffentlicht in: | Mol Ther Methods Clin Dev |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Gene & Cell Therapy
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6349562/ https://ncbi.nlm.nih.gov/pubmed/30705923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2018.12.007 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|